These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31772665)

  • 21. Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer.
    Lim D; Do Y; Kwon BS; Chang W; Lee MS; Kim J; Cho JG
    BMB Rep; 2020 Jun; 53(6):291-298. PubMed ID: 32438972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
    Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
    Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinoma.
    Zhao N; Sun BC; Zhao XL; Wang Y; Meng J; Che N; Dong XY; Gu Q
    Int J Clin Exp Pathol; 2015; 8(12):15759-68. PubMed ID: 26884845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasculogenic mimicry in head and neck tumors: a narrative review.
    Yue Y; Lou Y; Liu X; Peng X
    Transl Cancer Res; 2021 Jun; 10(6):3044-3052. PubMed ID: 35116612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of norcantharidin on melanoma tumor growth and vasculogenic mimicry by suppressing MMP-2 expression.
    Wang Z; You D; Lu M; He Y; Yan S
    Oncol Lett; 2017 Mar; 13(3):1660-1664. PubMed ID: 28454306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
    Rong X; Huang B; Qiu S; Li X; He L; Peng Y
    Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional roles of microRNAs in vasculogenic mimicry and resistance to therapy in human cancers: an update.
    García-Hernández AP; Sánchez-Sánchez G; Carlos-Reyes A; López-Camarillo C
    Expert Rev Clin Immunol; 2024 Aug; 20(8):913-926. PubMed ID: 38712535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.
    Cheng R; Cai XR; Ke K; Chen YL
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered in vivo and in vitro tumor model recapitulates vasculogenic mimicry signatures in melanoma.
    Shuai Q; Xu X; Liang Y; Halbiyat Z; Lu X; Hu Z; Peng Z; An J; Feng Z; Huang T; Zhao H; Liu Z; Xu J; Xie J
    Bioeng Transl Med; 2024 Jul; 9(4):e10648. PubMed ID: 39036079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets.
    Tang H; Chen L; Liu X; Zeng S; Tan H; Chen G
    Front Pharmacol; 2024; 15():1346719. PubMed ID: 38694917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.
    Xu MR; Wei PF; Suo MZ; Hu Y; Ding W; Su L; Zhu YD; Song WJ; Tang GH; Zhang M; Li P
    Biomed Res Int; 2019; 2019():6543230. PubMed ID: 30723742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research progress in vasculogenic mimicry in 
multiple tumors].
    Bai J; Xu Z; Liao C; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):357-364. PubMed ID: 28364113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells.
    Maiti A; Qi Q; Peng X; Yan L; Takabe K; Hait NC
    Int J Oncol; 2019 Jul; 55(1):116-130. PubMed ID: 31059004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
    Tao W; Sun W; Zhu H; Zhang J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of leptin receptor in human glioblastoma: Correlation with vasculogenic mimicry and poor prognosis.
    Han G; Li Y; Cao Y; Yue Z; Zhang Y; Wang L; Liu J
    Oncotarget; 2017 Aug; 8(35):58163-58171. PubMed ID: 28938545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.
    Tang J; Wang J; Fan L; Li X; Liu N; Luo W; Wang J; Wang Y; Wang Y
    Oncotarget; 2016 Apr; 7(17):24050-62. PubMed ID: 26992227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
    Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
    Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling pathways in tumor vasculogenic mimicry.
    Vartanian AA
    Biochemistry (Mosc); 2012 Sep; 77(9):1044-55. PubMed ID: 23157265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.